Free Trial

Genmab A/S (OTCMKTS:GNMSF) Stock Price Passes Below 200 Day Moving Average - Time to Sell?

Genmab A/S logo with Medical background

Shares of Genmab A/S (OTCMKTS:GNMSF - Get Free Report) crossed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $211.31 and traded as low as $190.50. Genmab A/S shares last traded at $190.50, with a volume of 22 shares trading hands.

Genmab A/S Trading Up 4.4 %

The firm has a 50 day moving average price of $203.93 and a 200 day moving average price of $210.35. The stock has a market capitalization of $13.25 billion, a PE ratio of 11.45 and a beta of 1.10.

Genmab A/S (OTCMKTS:GNMSF - Get Free Report) last issued its quarterly earnings results on Wednesday, February 12th. The company reported $5.70 EPS for the quarter, topping analysts' consensus estimates of $0.46 by $5.24. Genmab A/S had a return on equity of 19.75% and a net margin of 36.30%.

About Genmab A/S

(Get Free Report)

Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; and Amivantamab for advanced or metastatic gastric or esophageal cancer and NSCLC.

Featured Articles

Should You Invest $1,000 in Genmab A/S Right Now?

Before you consider Genmab A/S, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genmab A/S wasn't on the list.

While Genmab A/S currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Big Week Reveals a Rare Growth Story in a Shaky Market
Buy the Fear: 3 Down Stocks That Could 10x Your Profits
Congress Bought THESE Stocks as Tariffs Tanked the Market

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines